Sulodexide in Controlling the Recurrence of Psoriasis

Clinical trial NCT06982196 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06982196
Sponsor: Xijing Hospital
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Psoriasis (PsO)Randomised Controlled Trial

Start date: 2025-04-20
Primary completion: 2026-06-30
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.